-
1
HINT1 suppression protects against age-related cardiac dysfunction by enhancing mitochondrial biogenesis
Published 2025-03-01Get full text
Article -
2
-
3
Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
Published 2022-06-01Get full text
Article -
4
Radiomics-based Machine Learning Approach to Predict Chemotherapy Responses in Colorectal Liver Metastases
Published 2025-01-01Get full text
Article -
5
Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
Published 2022-06-01“…Methods and results We analysed 72 consecutive patients with moderate to severe AS who underwent 99mTc‐pyrophosphate (PYP) scintigraphy at Kumamoto University Hospital from January 2012 to September 2020. …”
Get full text
Article -
6
A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
Published 2022-06-01Get full text
Article -
7
-
8
Successful Treatment of Cisplatin Overdose with Plasma Exchange
Published 2010-01-01Get full text
Article -
9
Primary Diaphragmatic Dedifferentiated Liposarcoma in a Young Female Patient after Delivery
Published 2016-01-01Get full text
Article -
10
-
11
-
12
A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab
Published 2015-01-01Get full text
Article -
13
-
14
An Embedded Reconfigurable IP Core with Variable Grain Logic Cell Architecture
Published 2008-01-01Get full text
Article -
15
Geographical Flushing of the Children’s Face: A New Clinical Entity?
Published 2013-01-01Get full text
Article -
16
Cobalt Hydroxide Modification of TiO2 Nanosheets for Visible-Light-Responsive Photocatalysts
Published 2025-01-01Get full text
Article -
17
Spontaneous Rupture of an Unscarred Gravid Uterus in a Primigravid Woman at 32 Weeks of Gestation
Published 2014-01-01Get full text
Article -
18
Microdifferential Pressure Measurement Device for Cellular Microenvironments
Published 2024-12-01Get full text
Article -
19
-
20
Identifying factors for pembrolizumab eligibility in head and neck cancer
Published 2025-02-01Get full text
Article